Literature DB >> 24928145

Novel recessive myotilin mutation causes severe myofibrillar myopathy.

Joachim Schessl1, Elisa Bach, Simone Rost, Sarah Feldkirchner, Christiana Kubny, Stefan Müller, Franz-Georg Hanisch, Wolfram Kress, Benedikt Schoser.   

Abstract

We identified the first homozygous and hence recessive mutation in the myotilin gene (MYOT) in a family affected by a severe myofibrillar myopathy (MFM). MFM is a rare, progressive and devastating disease of human skeletal muscle with distinct histopathological pattern of protein aggregates and myofibrillar degeneration. So far, only heterozygous missense mutations in MYOT have been associated with autosomal dominant myofibrillar myopathy, limb-girdle muscular dystrophy type 1A and distal myopathy. Myotilin itself is highly expressed in skeletal and cardiac muscle and is localized at the Z-disc and therefore interacts in sarcomere assembly. We performed whole-exome sequencing in a German family clinically diagnosed with MFM and identified a homozygous mutation in exon 2, c.16C > G (p.Arg6Gly). Using laser microdissection followed by quantitative mass spectrometry, we identified the myotilin protein as one component showing the highest increased abundance in the aggregates in the index patient. We suggest that the combined approach has a high potential as a new tool for the confirmation of unclassified variants which are found in whole-exome sequencing approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24928145     DOI: 10.1007/s10048-014-0410-4

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  22 in total

Review 1.  Myofibrillar myopathies: a clinical and myopathological guide.

Authors:  Rolf Schröder; Benedikt Schoser
Journal:  Brain Pathol       Date:  2009-07       Impact factor: 6.508

Review 2.  Myofibrillar myopathies.

Authors:  Duygu Selcen; Andrew G Engel
Journal:  Handb Clin Neurol       Date:  2011

3.  Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy.

Authors:  P Salmikangas; O M Mykkänen; M Grönholm; L Heiska; J Kere; O Carpén
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

4.  Myotilin is mutated in limb girdle muscular dystrophy 1A.

Authors:  M A Hauser; S K Horrigan; P Salmikangas; U M Torian; K D Viles; R Dancel; R W Tim; A Taivainen; L Bartoloni; J M Gilchrist; J M Stajich; P C Gaskell; J R Gilbert; J M Vance; M A Pericak-Vance; O Carpen; C A Westbrook; M C Speer
Journal:  Hum Mol Genet       Date:  2000-09-01       Impact factor: 6.150

Review 5.  Myofibrillar myopathies.

Authors:  Duygu Selcen
Journal:  Curr Opin Neurol       Date:  2010-10       Impact factor: 5.710

6.  Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.

Authors:  Sarah Feldkirchner; Maggie C Walter; Stefan Müller; Christiana Kubny; Sabine Krause; Wolfram Kress; Franz-Georg Hanisch; Benedikt Schoser; Joachim Schessl
Journal:  Neuromuscul Disord       Date:  2013-03-13       Impact factor: 4.296

7.  Defective myotilin homodimerization caused by a novel mutation in MYOT exon 9 in the first Japanese limb girdle muscular dystrophy 1A patient.

Authors:  Sherine Shalaby; Hiroaki Mitsuhashi; Chie Matsuda; Narihiro Minami; Satoru Noguchi; Ikuya Nonaka; Ichizo Nishino; Yukiko K Hayashi
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

8.  Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly.

Authors:  Paula Salmikangas; Peter F M van der Ven; Maciej Lalowski; Anu Taivainen; Fang Zhao; Heli Suila; Rolf Schröder; Pekka Lappalainen; Dieter O Fürst; Olli Carpén
Journal:  Hum Mol Genet       Date:  2003-01-15       Impact factor: 6.150

9.  Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients.

Authors:  Duygu Selcen; Kinji Ohno; Andrew G Engel
Journal:  Brain       Date:  2004-01-07       Impact factor: 13.501

10.  Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy.

Authors:  G Vattemi; M Neri; S Piffer; P Vicart; F Gualandi; M Marini; V Guglielmi; M Filosto; P Tonin; A Ferlini; G Tomelleri
Journal:  Acta Myol       Date:  2011-10
View more
  6 in total

1.  Homozygous recessive MYH2 mutation mimicking dominant MYH2 associated myopathy.

Authors:  Andrew R Findlay; Matthew B Harms; Alan Pestronk; Conrad C Weihl
Journal:  Neuromuscul Disord       Date:  2018-05-21       Impact factor: 4.296

2.  Dynamic transcriptome profiles of skeletal muscle tissue across 11 developmental stages for both Tongcheng and Yorkshire pigs.

Authors:  Yuqiang Zhao; Ji Li; Huijing Liu; Yu Xi; Ming Xue; Wanghong Liu; Zhenhua Zhuang; Minggang Lei
Journal:  BMC Genomics       Date:  2015-05-12       Impact factor: 3.969

Review 3.  Single nucleotide variations: biological impact and theoretical interpretation.

Authors:  Panagiotis Katsonis; Amanda Koire; Stephen Joseph Wilson; Teng-Kuei Hsu; Rhonald C Lua; Angela Dawn Wilkins; Olivier Lichtarge
Journal:  Protein Sci       Date:  2014-10-20       Impact factor: 6.725

4.  Panorama of the distal myopathies.

Authors:  Marco Savarese; Jaakko Sarparanta; Anna Vihola; Per Harald Jonson; Mridul Johari; Salla Rusanen; Peter Hackman; Bjarne Udd
Journal:  Acta Myol       Date:  2020-12-01

5.  Commercial genetic testing for type 2 polysaccharide storage myopathy and myofibrillar myopathy does not correspond to a histopathological diagnosis.

Authors:  Stephanie J Valberg; Carrie J Finno; Marisa L Henry; Melissa Schott; Deborah Velez-Irizarry; Sichong Peng; Erica C McKenzie; Jessica L Petersen
Journal:  Equine Vet J       Date:  2020-10-29       Impact factor: 2.888

Review 6.  The Role of Z-disc Proteins in Myopathy and Cardiomyopathy.

Authors:  Kirsty Wadmore; Amar J Azad; Katja Gehmlich
Journal:  Int J Mol Sci       Date:  2021-03-17       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.